1Bussemarkers MJ,van Bokhoven A,Verhaegh GW,et al.DD3:a new prostate specific gene,highly overexpressed in prostate cancer[J].Cancer Res,1999,59(23):5975-5979.
2Nash AF,Melezinek I.The role of prostate specific antigen measurement in the detection and management of prostate cancer[J].Endocr Relat Cancer,2000,7(1):37-51.
3Tinzl M,Marberger M,Horvath S,et al.DD3Pca3 RNA analysis in urine-a new perspective for detecting prostate cancer[J].Eur Urol,2004,46(2):182-186.
4de Kok JB,Verhaegh GW,Roelofs RW,et al.DD3(Pca3),a very sensitive and specific marker to detect prostate tumors[J].Cancer Res,2002,62(9):2695-2698.
5Liag P,Pardee AB.Differential display.A general protocol[J].Mol Biotechnol,1998,10(3):261-267.
6Gandini O,Luci L,Stigliano A,et al.Is DD3 a new prostate-specific gene?[J].Anticancer Res,2003,23(1A):305-308.
7Schalken JA,Hessels D,Verhaegh G.New targets for therapy in prostate cancer:differential display code 3 (DD3(Pca3)),a highly prostate cancer-specific gene[J].Urology,2003,62(5):34-43.
8Landers KA,Burger MJ,Tebay MA,et al.Use of multiple biomarkers for a molecular diagnosis of prostate cancer[J].Int J Cancer,2004,17.
9Thelen P,Burfeind P,Grzmil M,et al.cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections[J].Int J Oncol,2004,24(5):1085-1092.
10Bussemakers MJ.Changes in gene expression and target for therapy[J].Eur Urol,1999,35(5-6):408-412.
